SPRUCE BIOSCIENCES, INC. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Spruce Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Spruce Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.41M, a 31.1% increase year-over-year.
  • Spruce Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$43.2M, a 18.3% increase year-over-year.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$52M, a 9.96% decline from 2022.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$47.3M, a 12.4% decline from 2021.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$42.1M, a 43% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$52M -$4.71M -9.96% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$47.3M -$5.22M -12.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$42.1M -$12.7M -43% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$29.4M -$16.3M -124% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$13.1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.